Systemic sclerosis-associated pulmonary hypertension: Short- and long-term effects of epoprostenol (prostacyclin)
Open Access
- 1 December 1999
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 42 (12) , 2638-2645
- https://doi.org/10.1002/1529-0131(199912)42:12<2638::aid-anr20>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infectionPublished by Elsevier ,1997
- Prevalence of Pulmonary Hypertension in Limited and Diffuse SclerodermaChest, 1996
- CLINICAL PROBLEMS: The LungsRheumatic Disease Clinics of North America, 1996
- Pulmonary hypertension in systemic sclerosis: an analysis of 17 patientsRheumatology, 1996
- Primary Pulmonary HypertensionChest, 1993
- Lung disease in systemic sclerosis (scleroderma)Bailliere's Clinical Rheumatology, 1993
- Survival in Patients with Primary Pulmonary HypertensionAnnals of Internal Medicine, 1991
- Predictors of survival in systemic sclerosis (Scleroderma)Arthritis & Rheumatism, 1991
- Outcome of Renal Crisis in Systemic Sclerosis: Relation to Availability of Angiotensin Converting Enzyme (ACE) InhibitorsAnnals of Internal Medicine, 1990
- The pulmonary pathologic manifestations of the CREST syndromeHuman Pathology, 1990